EUVIMEDEUVIMED entdecken
Crossref

Poly(2-oxazoline)- and Poly(2-oxazine)-Based Formulation Library Reveals Limits of Solubility Parameter-Based Drug-Polymer Compatibility Prediction

Malik Salman Haider iD, Robert Luxenhofer iD

Biomacromolecules · 09.11.2026 · 27 (11) · 7767-7787

DOI: 10.1021/acs.biomac.6c01970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 09.10.2026. Verfasst von Malik Salman Haider und 1 weiteren Autor:innen. Beteiligte Einrichtung: Functional Polymer Materials, Chair for Advanced Materials Synthesis, Institute for Functional Materials and Biofabrication, Department of Chemistry …. Hauptthemen laut MEDLINE: Oxazoles, Polymers, Oxazines. Die Arbeit nennt 122 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Four structurally related poly(2-oxazoline) (POx)- and poly(2-oxazine) (POzi)-based ABA triblock copolymers were evaluated across 21 poorly water-soluble drugs to assess whether Hansen solubility parameters (HSPs) predict polymer-specific formulation performance. HSPs were calculated using Hoftyzer-Van Krevelen (HnV) and Yamamoto molecular break (YMB) methods, with semi-empirical polymer HSPs derived from solvent−solubility profiles. The polymers showed drug-specific performance, with maximum loading capacities exceeding 40 wt % for four drugs and 30 wt % for another four drugs. However, Ra showed limited discriminatory power. Among 20 drugs with YMB-derived Ra values, the lowest-Ra polymer was experimentally best for only 4 (20%), while Ra-based and experimental within-drug pairwise rankings agreed in 59 of 119 comparisons (49.6%). Significant cross-drug correlations for two polymers were positive, opposite to the expected trend. Despite this limited predictive performance, the resulting formulation library provides a broad experimental platform for identifying polymer-drug combinations for subsequent application-specific preclinical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxazolesPolymersOxazinesSolubility

Stichwörter der Autor:innen

hydrophobic drugsmicellespolymer-drug interactionsolubility enhancement

Substanzen

poly(2-oxazoline)OxazolesPolymersOxazines

Autor:innen und Institutionen

  • Functional Polymer Materials, Chair for Advanced Materials Synthesis, Institute for Functional Materials and Biofabrication, Department of Chemistry and Pharmacy, Julius-Maximilians-University Würzburg, Röntgenring 11,…
  • Department of Ophthalmology, Universitätsklinikum Würzburg, Josef-Schneider Str. 11, Würzburg97080, Germany.
  • Soft Matter Chemistry, Department of Chemistry, and Helsinki Institute of Sustainability Science, Faculty of Science, University of Helsinki, Helsinki00014, Finland.

ORCID-Profile: Malik Salman Haider, Robert Luxenhofer

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Haider, M. S., & Luxenhofer, R. (2026). Poly(2-oxazoline)- and Poly(2-oxazine)-Based Formulation Library Reveals Limits of Solubility Parameter-Based Drug-Polymer Compatibility Prediction. Biomacromolecules, 27(11), 7767-7787. https://doi.org/10.1021/acs.biomac.6c01970

Vancouver

Haider MS, Luxenhofer R. Poly(2-oxazoline)- and Poly(2-oxazine)-Based Formulation Library Reveals Limits of Solubility Parameter-Based Drug-Polymer Compatibility Prediction. Biomacromolecules. 2026;27(11):7767-7787. doi:10.1021/acs.biomac.6c01970

BibTeX
@article{Haider2026,
  author = {Haider, Malik Salman and Luxenhofer, Robert},
  title = {Poly(2-oxazoline)- and Poly(2-oxazine)-Based Formulation Library Reveals Limits of Solubility Parameter-Based Drug-Polymer Compatibility Prediction},
  journal = {Biomacromolecules},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {7767--7787},
  doi = {10.1021/acs.biomac.6c01970}
}
Kostenlos starten →